Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed1
Recruiting1
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05649098Early Phase 1Recruiting
Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
Skin Diseases
PrincipalinvestigatorStart date: 2023-06-12
NCT03544866Completed
The Impact of Pediatric Skin Disorders: The "Big" Study
Chronic Pediatric Skin Conditions
PrincipalinvestigatorStart date: 2018-11-16
NCT06545695Phase 1/2Not Yet Recruiting
Epidermal Growth Factor Receptor Inhibition for Keratinopathies
Epidermolytic IchthyosisPachyonychia CongenitaPalmoplantar Keratoderma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05649098Early Phase 1PrincipalInvestigator

Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders

Skin Diseases
Recruiting
NCT03544866PrincipalInvestigator

The Impact of Pediatric Skin Disorders: The "Big" Study

Chronic Pediatric Skin Conditions
Completed
NCT06545695Phase 1/2PrincipalInvestigator

Epidermal Growth Factor Receptor Inhibition for Keratinopathies

Epidermolytic IchthyosisPachyonychia CongenitaPalmoplantar Keratoderma
Not Yet Recruiting

All 3 trials loaded